benefits of cd38 inhibitor with 5-amino-1mq as theranostic target in oncology | Journal Translational Medicine CD38 as a therapeutic target
CD38 as a therapeutic target for MM CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance Frontiers Frontiers Modulating CD38 enzymatic activity during antibody based immunotherapy in multiple myeloma: a basic science perspective Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



